Cargando…
Structure–Reactivity Studies of 2-Sulfonylpyrimidines Allow Selective Protein Arylation
[Image: see text] Protein arylation has attracted much attention for developing new classes of bioconjugates with improved properties. Here, we have evaluated 2-sulfonylpyrimidines as covalent warheads for the mild, chemoselective, and metal free cysteine S-arylation. 2-Sulfonylpyrimidines react rap...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515483/ https://www.ncbi.nlm.nih.gov/pubmed/37657082 http://dx.doi.org/10.1021/acs.bioconjchem.3c00322 |
_version_ | 1785108957272997888 |
---|---|
author | Pichon, Maëva M. Drelinkiewicz, Dawid Lozano, David Moraru, Ruxandra Hayward, Laura J. Jones, Megan McCoy, Michael A. Allstrum-Graves, Samuel Balourdas, Dimitrios-Ilias Joerger, Andreas C. Whitby, Richard J. Goldup, Stephen M. Wells, Neil Langley, Graham J. Herniman, Julie M. Baud, Matthias G. J. |
author_facet | Pichon, Maëva M. Drelinkiewicz, Dawid Lozano, David Moraru, Ruxandra Hayward, Laura J. Jones, Megan McCoy, Michael A. Allstrum-Graves, Samuel Balourdas, Dimitrios-Ilias Joerger, Andreas C. Whitby, Richard J. Goldup, Stephen M. Wells, Neil Langley, Graham J. Herniman, Julie M. Baud, Matthias G. J. |
author_sort | Pichon, Maëva M. |
collection | PubMed |
description | [Image: see text] Protein arylation has attracted much attention for developing new classes of bioconjugates with improved properties. Here, we have evaluated 2-sulfonylpyrimidines as covalent warheads for the mild, chemoselective, and metal free cysteine S-arylation. 2-Sulfonylpyrimidines react rapidly with cysteine, resulting in stable S-heteroarylated adducts at neutral pH. Fine tuning the heterocyclic core and exocyclic leaving group allowed predictable S(N)Ar reactivity in vitro, covering >9 orders of magnitude. Finally, we achieved fast chemo- and regiospecific arylation of a mutant p53 protein and confirmed arylation sites by protein X-ray crystallography. Hence, we report the first example of a protein site specifically S-arylated with iodo-aromatic motifs. Overall, this study provides the most comprehensive structure–reactivity relationship to date on heteroaryl sulfones and highlights 2-sulfonylpyrimidine as a synthetically tractable and protein compatible covalent motif for targeting reactive cysteines, expanding the arsenal of tunable warheads for modern covalent ligand discovery. |
format | Online Article Text |
id | pubmed-10515483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-105154832023-09-23 Structure–Reactivity Studies of 2-Sulfonylpyrimidines Allow Selective Protein Arylation Pichon, Maëva M. Drelinkiewicz, Dawid Lozano, David Moraru, Ruxandra Hayward, Laura J. Jones, Megan McCoy, Michael A. Allstrum-Graves, Samuel Balourdas, Dimitrios-Ilias Joerger, Andreas C. Whitby, Richard J. Goldup, Stephen M. Wells, Neil Langley, Graham J. Herniman, Julie M. Baud, Matthias G. J. Bioconjug Chem [Image: see text] Protein arylation has attracted much attention for developing new classes of bioconjugates with improved properties. Here, we have evaluated 2-sulfonylpyrimidines as covalent warheads for the mild, chemoselective, and metal free cysteine S-arylation. 2-Sulfonylpyrimidines react rapidly with cysteine, resulting in stable S-heteroarylated adducts at neutral pH. Fine tuning the heterocyclic core and exocyclic leaving group allowed predictable S(N)Ar reactivity in vitro, covering >9 orders of magnitude. Finally, we achieved fast chemo- and regiospecific arylation of a mutant p53 protein and confirmed arylation sites by protein X-ray crystallography. Hence, we report the first example of a protein site specifically S-arylated with iodo-aromatic motifs. Overall, this study provides the most comprehensive structure–reactivity relationship to date on heteroaryl sulfones and highlights 2-sulfonylpyrimidine as a synthetically tractable and protein compatible covalent motif for targeting reactive cysteines, expanding the arsenal of tunable warheads for modern covalent ligand discovery. American Chemical Society 2023-09-01 /pmc/articles/PMC10515483/ /pubmed/37657082 http://dx.doi.org/10.1021/acs.bioconjchem.3c00322 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Pichon, Maëva M. Drelinkiewicz, Dawid Lozano, David Moraru, Ruxandra Hayward, Laura J. Jones, Megan McCoy, Michael A. Allstrum-Graves, Samuel Balourdas, Dimitrios-Ilias Joerger, Andreas C. Whitby, Richard J. Goldup, Stephen M. Wells, Neil Langley, Graham J. Herniman, Julie M. Baud, Matthias G. J. Structure–Reactivity Studies of 2-Sulfonylpyrimidines Allow Selective Protein Arylation |
title | Structure–Reactivity
Studies of 2-Sulfonylpyrimidines
Allow Selective Protein Arylation |
title_full | Structure–Reactivity
Studies of 2-Sulfonylpyrimidines
Allow Selective Protein Arylation |
title_fullStr | Structure–Reactivity
Studies of 2-Sulfonylpyrimidines
Allow Selective Protein Arylation |
title_full_unstemmed | Structure–Reactivity
Studies of 2-Sulfonylpyrimidines
Allow Selective Protein Arylation |
title_short | Structure–Reactivity
Studies of 2-Sulfonylpyrimidines
Allow Selective Protein Arylation |
title_sort | structure–reactivity
studies of 2-sulfonylpyrimidines
allow selective protein arylation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515483/ https://www.ncbi.nlm.nih.gov/pubmed/37657082 http://dx.doi.org/10.1021/acs.bioconjchem.3c00322 |
work_keys_str_mv | AT pichonmaevam structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT drelinkiewiczdawid structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT lozanodavid structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT moraruruxandra structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT haywardlauraj structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT jonesmegan structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT mccoymichaela structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT allstrumgravessamuel structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT balourdasdimitriosilias structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT joergerandreasc structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT whitbyrichardj structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT goldupstephenm structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT wellsneil structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT langleygrahamj structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT hernimanjuliem structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation AT baudmatthiasgj structurereactivitystudiesof2sulfonylpyrimidinesallowselectiveproteinarylation |